A-1.6. Testimony

HHSC allows members of the public to submit two types of testimony to the DUR board:

  • Written testimony: submitted electronically or on paper in the weeks before the meeting
  • Public testimony: oral presentations on the day of the meeting

Your testimony must address one of the agenda items related to the preferred drug list, prospective or retrospective drug utilization reviews, or retrospective drug use criteria. You must complete one form for each type of presentation. Any special testimony instructions are announced before the meeting.

Individuals providing testimony must complete the appropriate testimony form and the Public Comment Registration form linked on the agenda.

A-1.6.1. Written Testimony

HHSC considers written comments by individuals advocating for products as a testimony before the board. Complete and submit the Written Testimony Registration (HHS Form 1334) to have your materials made available to the board for its review. HHSC publishes a new form for each meeting at least 10 business days before the meeting.

Your submission packet must include the form and any accompanying materials. You should submit the form and packet by email no sooner than the first day of the meeting month, and HHSC should receive it by the due date listed on the published meeting agenda on the HHSC website. You must include your name and the organization you represent or identify yourself as a private citizen on the form. Original form submissions are required. We do not accept photographs or reproductions.

Information about accompanying materials includes the following:

  • Must be a separate document not exceeding 10 pages
  • Must not require audiovisual equipment to review
  • Promotional or marketing materials are not allowed
  • Must not include protected health information or other confidential information

Refer to the Forms section for a link to the registration form.

A-1.6.2. Public Testimony

Complete and submit the Public Testimony Registration (HHS Form 1320). HHSC publishes a new form for each meeting. The form is available:

  • Online, beginning 10 days before the meeting
    • Original form submissions are required. We do not accept photographs or reproductions. Submit by email to HHSC.
  • At the meeting site

You may download and complete the form before the meeting. The form is only accepted the day of the meeting at the meeting location. Speakers should deliver their form during one of the following registration times:

  • Between 8 and 9 a. m. for preferred drug list agenda items
    • Scheduled for comment before the executive work session
  • Between 11:30 a. m. and 12:30 p. m. for prospective and retrospective drug utilization agenda items
    • Scheduled for comment after the executive session

HHSC staff are available on the day of the meeting to receive the form and ensure all information is provided.

Information about publicly testifying includes:

  • Testimony is limited to three minutes at the discretion of the Chair
  • Presenters should begin their presentation by stating their name and the organization represented and ensure your information is new and relevant to the agenda item
  • HHSC does not allow audiovisual equipment and marketing materials
  • The Chair may disallow presentations on non-actionable issues or issues not on the agenda or not within the Drug Utilization Review Board's responsibility.

Refer to the Forms section for a link to the registration form.